Regeneron Oncology Investor Event, ASCO 2020 Jun 12020 4:30 PM EDT Jun 1, 2020 | 4:30 PM EDT listen to webcast Supporting Materials Regeneron Oncology Investor Event, ASCO 2020 Presentation 2.2 MB Trial in Progress - Phase 1-2 for REGN5093 (METxMET) in MET-Altered Advanced NSCLC 1.1 MB Trial in Progress - Phase 1-2 for REGN5678 (PSMAxCD28) in mCRPC 1.3 MB Trial in Progress - Phase 3 for Libtayo in Adjuvant CSCC 218.1 KB Phase 2 of Libtayo in Advanced CSCC - Post Hoc Exploratory Analysis 142.7 KB Phase 2 of Libtayo in Advanced CSCC - Three-year follow-up 132 KB